These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 30664182)
1. miR‑16‑2‑3p inhibits cell proliferation and migration and induces apoptosis by targeting PDPK1 in maxillary primordium mesenchymal cells. Han T; Wu N; Wang Y; Shen W; Zou J Int J Mol Med; 2019 Mar; 43(3):1441-1451. PubMed ID: 30664182 [TBL] [Abstract][Full Text] [Related]
2. A new and important relationship between miRNA-147a and PDPK1 in radiotherapy. Wang LJ; Li NN; Xu SJ; Zhang F; Hao MH; Yang XJ; Cai XH; Qiu PY; Ji HL; Xu P J Cell Biochem; 2018 Apr; 119(4):3519-3527. PubMed ID: 29144017 [TBL] [Abstract][Full Text] [Related]
3. miR-718 is involved in malignancy of papillary thyroid cancer through repression of PDPK1. Wang X; Qi M Pathol Res Pract; 2018 Nov; 214(11):1787-1793. PubMed ID: 30166214 [TBL] [Abstract][Full Text] [Related]
4. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3. Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830 [TBL] [Abstract][Full Text] [Related]
6. The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1. Zheng F; Wu J; Tang Q; Xiao Q; Wu W; Hann SS J Cell Mol Med; 2018 Jan; 22(1):600-612. PubMed ID: 28840963 [TBL] [Abstract][Full Text] [Related]
7. miR-138-1* regulates aflatoxin B1-induced malignant transformation of BEAS-2B cells by targeting PDK1. Wang Y; Zhang Z; Wang H; Zhang Y; Ji M; Xu H; Wang C; Sun Z; Gao W; Wang SL Arch Toxicol; 2016 May; 90(5):1239-49. PubMed ID: 26084420 [TBL] [Abstract][Full Text] [Related]
8. Stomatin-Mediated Inhibition of the Akt Signaling Axis Suppresses Tumor Growth. Rahman NIA; Sato A; Tsevelnorov K; Shimizu A; Komeno M; Ahmat Amin MKB; Molla MR; Soh JEC; Nguyen LKC; Wada A; Kawauchi A; Ogita H Cancer Res; 2021 May; 81(9):2318-2331. PubMed ID: 33757977 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adenocarcinoma. Chen Q; Wang P; Fu Y; Liu X; Xu W; Wei J; Gao W; Jiang K; Wu J; Miao Y Oncol Rep; 2017 Dec; 38(6):3567-3573. PubMed ID: 29039566 [TBL] [Abstract][Full Text] [Related]
10. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway. Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539 [TBL] [Abstract][Full Text] [Related]
11. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2. Chen X; Hao B; Han G; Liu Y; Dai D; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J J Cell Biochem; 2015 Feb; 116(2):225-32. PubMed ID: 25160587 [TBL] [Abstract][Full Text] [Related]
12. lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma. Deng R; Zhang J; Chen J Int J Mol Med; 2019 Mar; 43(3):1157-1166. PubMed ID: 30592267 [TBL] [Abstract][Full Text] [Related]
13. miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10. Liu F; Lou K; Zhao X; Zhang J; Chen W; Qian Y; Zhao Y; Zhu Y; Zhang Y Int J Mol Med; 2018 Dec; 42(6):3027-3036. PubMed ID: 30272290 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway. Wang F; Li L; Chen Z; Zhu M; Gu Y Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965 [TBL] [Abstract][Full Text] [Related]
15. miRNA‑222 promotes liver cancer cell proliferation, migration and invasion and inhibits apoptosis by targeting BBC3. Liu Z; Sun J; Liu B; Zhao M; Xing E; Dang C Int J Mol Med; 2018 Jul; 42(1):141-148. PubMed ID: 29693134 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑93‑5p promotes the progression of human retinoblastoma by regulating the PTEN/PI3K/AKT signaling pathway. Cao Y; Xia F; Wang P; Gao M Mol Med Rep; 2018 Dec; 18(6):5807-5814. PubMed ID: 30365088 [TBL] [Abstract][Full Text] [Related]
17. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Ma Y; Qin H; Cui Y Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341 [TBL] [Abstract][Full Text] [Related]
18. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression. Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143 [TBL] [Abstract][Full Text] [Related]
19. miR-375 controls porcine pancreatic stem cell fate by targeting 3-phosphoinositide-dependent protein kinase-1 (Pdk1). Hu S; Zhang M; Sun F; Ren L; He X; Hua J; Peng S Cell Prolif; 2016 Jun; 49(3):395-406. PubMed ID: 27218665 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway. Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]